International Journal of Heart Failure

The Korean Society of Heart Failure (대한심부전학회)
권호 표지
DOI QR코드

DOI QR Code

Rationale, Design, and Interim Observations of the Steady Movement With Innovating Leadership for Heart Failure (SMILE HF) Registry: A Multicenter Prospective Cohort Registry for Patients With Acute Heart Failure

  • Jah Yeon Choi (Department of Cardiology, Korea University Guro Hospital) ;
  • Mi-Na Kim (Department of Cardiology, Korea University Anam Hospital) ;
  • Seongwoo Han (Department of Cardiology, Hallym University Dongtan Sacred Heart Hospital) ;
  • Sunki Lee (Department of Cardiology, Korea University Guro Hospital) ;
  • Myung Soo Park (Department of Cardiology, Hallym University Dongtan Sacred Heart Hospital) ;
  • Min Gyu Kong (Department of Cardiology, Soonchunhyang University Bucheon Hospital) ;
  • Sung-Hea Kim (Department of Cardiology, Konkuk University Hospital) ;
  • Yong-Hyun Kim (Department of Cardiology, Korea University Ansan Hospital) ;
  • Sang-Ho Jo (Department of Cardiology, Hallym University Sacred Heart Hospital) ;
  • Sungeun Kim (Department of Cardiology, Hallym University Kangdong Sacred Heart Hospital) ;
  • Seonghoon Choi (Department of Cardiology, Hallym University Kangnam Sacred Heart Hospital) ;
  • Jinsung Jeon (Department of Cardiology, Korea University Guro Hospital) ;
  • Jieun Lee (Department of Cardiology, Korea University Guro Hospital) ;
  • Byambakhand Battumur (Department of Cardiology, Korea University Guro Hospital) ;
  • Seong-Mi Park (Department of Cardiology, Korea University Anam Hospital) ;
  • Eung Ju Kim (Department of Cardiology, Korea University Guro Hospital) ;
  • SMILE HF Investigators (SMILE HF)
  • Received : 2024.02.25
  • Accepted : 2024.06.25
  • Published : 2024.07.30
Download PDF
⟨ Previous Next ⟩

Abstract

Background and Objectives: Heart failure (HF) is a leading cause of hospitalization and death worldwide. The Steady Movement with Innovating Leadership for Heart Failure (SMILE HF) aims to evaluate the clinical characteristics, management, hospital course, and long-term outcomes of patients hospitalized for acute HF in South Korea. Methods: This prospective, observational multicenter cohort study was conducted on consecutive patients hospitalized for acute HF in nine university hospitals since September 2019. Enrolment of 2000 patients should be completed in 2024, and follow-up is planned through 2025. Results: Interim analysis of 1,052 consecutive patients was performed to understand the baseline characteristics. The mean age was 69±15 years; 57.6% were male. The mean left ventricular ejection fraction was 39±15%. The prevalences of HF with reduced ejection fraction, HF with mildly reduced ejection fraction, and HF with preserved ejection fraction were 50.9%, 15.3%, and 29.2%. Ischemic cardiomyopathy (CMP) was the most common etiology (32%), followed by tachycardia-induced CMP (12.8%) and idiopathic dilated CMP (9.5%). The prescription rate of angiotensin-converting enzyme inhibitor/angiotensin receptor blockers/angiotensin receptor/neprilysin inhibitor, beta-blockers, spironolactone, and sodium-glucose cotransporter-2 inhibitors at discharge were 76.8%, 66.5%, 50.0%, and 17.5%, respectively. The post-discharge 90-day mortality and readmission rates due to HF aggravation were 2.0% and 6.4%, respectively. Our analysis reveals the current state of acute HF in South Korea. Conclusions: Our interim analysis provides valuable insights into the clinical characteristics, management, and early outcomes of acute HF patients in South Korea, highlighting the current state and treatment patterns in this population.

Keywords

Acknowledgement

This investigator-initiated trial was mainly funded by Yuhan and partially supported by Hanmi Pharmaceutical.

References

  1. Lee JH, Lim NK, Cho MC, Park HY. Epidemiology of heart failure in Korea: present and future. Korean Circ J 2016;46:658-64.
  2. Choi HM, Park MS, Youn JC. Update on heart failure management and future directions. Korean J Intern Med 2019;34:11-43.
  3. Cho H, Oh SH, Lee H, Cho HJ, Kang HY. The incremental economic burden of heart failure: a population-based investigation from South Korea. PLoS One 2018;13:e0208731.
  4. Abdin A, Schulz M, Riemer U, et al. Sacubitril/valsartan in heart failure: efficacy and safety in and outside clinical trials. ESC Heart Fail 2022;9:3737-50.
  5. Zou X, Shi Q, Vandvik PO, et al. Sodium-glucose cotransporter-2 inhibitors in patients with heart failure : a systematic review and meta-analysis. Ann Intern Med 2022;175:851-61.
  6. Olivella A, Almenar-Bonet L, Moliner P, et al. Role of vericiguat in management of patients with heart failure with reduced ejection fraction after worsening episode. ESC Heart Fail 2024;11:628-36.
  7. McDonagh TA, Metra M, Adamo M, et al. 2023 Focused update of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J 2023;44:3627-39.
  8. Heidenreich PA, Bozkurt B, Aguilar D, et al. 2022 AHA/ACC/HFSA Guideline for the management of heart failure: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation 2022;145:e895-1032.
  9. Lee SE, Lee HY, Cho HJ, et al. Clinical characteristics and outcome of acute heart failure in Korea: results from the Korean Acute Heart Failure Registry (KorAHF). Korean Circ J 2017;47:341-53.
  10. Youn JC, Han S, Ryu KH. Temporal trends of hospitalized patients with heart failure in Korea. Korean Circ J 2017;47:16-24.
  11. Lee CJ, Lee H, Yoon M, et al. Heart failure statistics 2024 update: a report from the Korean Society of Heart Failure. Int J Heart Fail 2024;6:56-69.
  12. Choi DJ, Han S, Jeon ES, et al.; KorHF Registry. Characteristics, outcomes and predictors of long-term mortality for patients hospitalized for acute heart failure: a report from the Korean Heart Failure Registry. Korean Circ J 2011;41:363-71.
  13. Sato N, Kajimoto K, Asai K, et al. Acute decompensated heart failure syndromes (ATTEND) registry. A prospective observational multicenter cohort study: rationale, design, and preliminary data. Am Heart J 2010;159:949-955.e1.
  14. Ide T, Kaku H, Matsushima S, et al. Clinical characteristics and outcomes of hospitalized patients with heart failure from the large-scale Japanese Registry of Acute Decompensated Heart Failure (JROADHF). Circ J 2021;85:1438-50.
  15. Damasceno A, Mayosi BM, Sani M, et al. The causes, treatment, and outcome of acute heart failure in 1006 Africans from 9 countries. Arch Intern Med 2012;172:1386-94.
  16. Chioncel O, Mebazaa A, Harjola VP, et al. Clinical phenotypes and outcome of patients hospitalized for acute heart failure: the ESC Heart Failure Long-Term Registry. Eur J Heart Fail 2017;19:1242-54.
  17. Hyun J, Cho JY, Youn JC, et al. Korean Society of Heart Failure Guidelines for the management of heart failure: advanced and acute heart failure. Int J Heart Fail 2023;5:111-26.
  18. Youn JC, Kim D, Cho JY, et al. Korean Society of Heart Failure Guidelines for the management of heart failure: treatment. Int J Heart Fail 2023;5:66-81.
  19. Lee SE, Cho HJ, Lee HY, et al. A multicentre cohort study of acute heart failure syndromes in Korea: rationale, design, and interim observations of the Korean Acute Heart Failure (KorAHF) registry. Eur J Heart Fail 2014;16:700-8.
  20. Sze S, Pellicori P, Zhang J, Weston J, Clark AL. Identification of frailty in chronic heart failure. JACC Heart Fail 2019;7:291-302.
  21. Richter D, Guasti L, Walker D, et al. Frailty in cardiology: definition, assessment and clinical implications for general cardiology. A consensus document of the Council for Cardiology Practice (CCP), Association for Acute Cardio Vascular Care (ACVC), Association of Cardiovascular Nursing and Allied Professions (ACNAP), European Association of Preventive Cardiology (EAPC), European Heart Rhythm Association (EHRA), Council on Valvular Heart Diseases (VHD), Council on Hypertension (CHT), Council of Cardio-Oncology (CCO), Working Group (WG) Aorta and Peripheral Vascular Diseases, WG e-Cardiology, WG Thrombosis, of the European Society of Cardiology, European Primary Care Cardiology Society (EPCCS). Eur J Prev Cardiol 2022;29:216-27.
  22. Ijaz N, Buta B, Xue QL, et al. Interventions for frailty among older adults with cardiovascular disease: JACC State-of-the-Art Review. J Am Coll Cardiol 2022;79:482-503.
  23. Vitale C, Spoletini I, Rosano GM. The dual burden of frailty and heart failure. Int J Heart Fail 2024;6:107-16.
  24. Klassen P, Mazariegos M, Deurenberg P, Solomons NW, Furst P. Hydrational status assessed by bioelectrical impedance spectroscopy and dilution methods in patients with classical dengue fever. Ann N Y Acad Sci 2000;904:163-70.
  25. Sartorio A, Malavolti M, Agosti F, et al. Body water distribution in severe obesity and its assessment from eight-polar bioelectrical impedance analysis. Eur J Clin Nutr 2005;59:155-60.
  26. Davenport A, Sayed RH, Fan S. Is extracellular volume expansion of peritoneal dialysis patients associated with greater urine output? Blood Purif 2011;32:226-31.